[SGLT2 inhibitors: a new therapeutic class for the treatment of type 2 diabetes mellitus].

Abstract

SGLT2 (Sodium Glucose co-Transporter 2 Inhibitors) inhibitors are a new group of oral medications for the treatment of type 2 diabetes mellitus patients. These medications interfere with the process of glucose reabsorption in the proximal convoluted tubules in the kidneys, therefore increasing both glucose and water diuresis. SGLT2 inhibitors were found to… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.